Pulmonary Hypertension Research and Diagnosis Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
33pct
2d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Pulmonary Hypertension Research and Diagnosis Act of 2015 This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to establish the Interagency Pulmonary Hypertension Coordinating Committee. The committee must monitor research and annually summarize research and medical advances regarding pulmonary hypertension. The committee must develop a comprehensive strategic plan to improve health outcomes for individuals with pulmonary hypertension. The plan must include recommendations regarding pulmonary hypertension diagnosis, research, transplantation criteria, public awareness, and health care delivery. HHS must report on activities related to improving health outcomes for individuals with pulmonary hypertension. The report must include information regarding pulmonary hypertension epidemiology, treatment, support available to individuals, and research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;HR 4662 School-Based Asthma Management Program Act; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; HR 2028 Further Continuing and Security Assistance Appropriations Act, 2017; Issues related to research at the National Institutes of Health; Issues related to Moonshot Initiative; Issues related to the President's Budget; Issues related to the Budget Control Act;
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; H.R.5912 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016;; HR 4662 School-Based Asthma Management Program Act; H.R. 4768, the Separation of Powers Restoration Act of 2016; HR 5263 Women and Lung Cancer Research and Preventive Services Act of 2016; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; HR 2028 Further Continuing and Security Assistance Appropriations Act, 2017; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · fourth_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives HR 3742: Access to Marketplace Insurance Act
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;HR 4662 School-Based Asthma Management Program Act; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; Issues related to research at the National Institutes of Health; Issues related to Moonshot Initiative; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; H.R.5912 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 2577 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; HR 4974 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016; H.R.5325 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act, 2017, and Zika Response and Preparedness Act; HR 4662 School-Based Asthma Management Program Act; H.R. 4768, the Separation of Powers Restoration Act of 2016; HR 5263 Women and Lung Cancer Research and Preventive Services Act of 2016; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives HR 3742: Access to Marketplace Insurance Act
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
2016 · second_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to the House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Issues related to the House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 2577 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; HR 4974 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016; H. Res. 717 National Cancer Research Month; S. Res. 459, National Cancer Research Month; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;
2016 · second_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to the House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2016 · second_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives HR 3742: Access to Marketplace Insurance Act
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
2016 · first_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; Issues related to Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2016 · first_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; Issues related to Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; Issues related to Commerce, Justice, Science, and Related Agencies Appropriations; Issues related to Defense Appropriations; Issues related to Labor, Health and Human Services, Education, and Related Agencies Appropriations; Issues related to Interior, Environment, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs and Related Agencies Appropriations; Issues related to State, Foreign Operations, and Related Programs Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act; HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $100,000 · Firm income: Not reported
2016 · first_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives HR 3742: Access to Marketplace Insurance Act
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
2015 · fourth_quarter · Health Issues
H.R. 3537, Synthetic Drug Control Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions H.R. 3520, Pulmonary Hypertension Research and Diagnosis Act of 2015, all provisions H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions S. 1945, Mental Health Reform Act of 2015, all provisions H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions H.R.6, 21st Century Cures Act, all provisions H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Radiation Oncology Therapy Coding Medical Licensure - The Interstate Medical Licensure Compact Prescription Drug Diversion and Abuse Physician Owned Hospitals Health Savings Accounts - Prescription requirements for over-the-counter medications Opioid Abuse Telemedicine Drug Pricing Electronic Health Records (EHR) interoperability and certification Meaningful Use/hardship exemptions and Stage 3 regulations Precision Medicine Cybersecurity Sunshine Act FDA/NIH Modernization Laboratory Developed Tests (LDT) Mental health and HIPAA privacy law HIPAA Chronic care Child-resistant packaging for energy drinks COBRA grace period Dietary guidelines ICD-10 Antibiotic resistance Pre-diabetes Hypertension Homelessness - impact on health XR-29-2013 related penalty/12 month delay Clinical Laboratory Improvement Amendments (CLIA)/oversight modernization
2015 · fourth_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res. 78 FY2016 Continuing Appropriations; H.R.2029 Consolidated Appropriations Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2015 · fourth_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.2 Medicare Access and CHIP Reauthorization Act of 2015; H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; H.R. 2685 Defense Appropriations; S. 1558 Defense Appropriations; H.R. 2822 Interior, Environment, and Related Agencies Appropriations; S. 1645 Interior, Environment, and Related Agencies Appropriations; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; H.R. 2772 State, Foreign Operations, and Related Programs Appropriations; S. 1725 State, Foreign Operations, and Related Programs Appropriations; H.R. 2577 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res. 78 FY2016 Continuing Appropriations; H.R.2029 Consolidated Appropriations Act; HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; Issues related to the President's Budget; Issues related to the Budget Control Act;
2015 · fourth_quarter · Health Issues
H.R. 3537, Synthetic Drug Control Act of 2015, all provisions H.R. 3940, Meaningful Use Hardship Relief Act of 2015, all provisions H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions H.R. 3309, Flex-IT 2 Act, all provisions S. 2141, Transparent Ratings on Usability and Security to Transform Information Technology (TRUST IT) Act of 2015, all provisions H.R. 3520, Pulmonary Hypertension Research and Diagnosis Act of 2015, all provisions H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions S. 1945, Mental Health Reform Act of 2015, all provisions H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions H.R.6, 21st Century Cures Act, all provisions H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2015, all provisions H.R. 3770, End Surprise Billing Act of 2015, all provisions Radiation Oncology Therapy Coding Medical Licensure - The Interstate Medical Licensure Compact Prescription Drug Diversion and Abuse Physician Owned Hospitals Health Savings Accounts - Prescription requirements for over-the-counter medications Opioid Abuse Telemedicine Drug Pricing Electronic Health Records (EHR) interoperability and certification Meaningful Use/hardship exemptions and Stage 3 regulations Precision Medicine Cybersecurity Sunshine Act FDA/NIH Modernization Laboratory Developed Tests (LDT) Mental health and HIPAA privacy law HIPAA Chronic care Child-resistant packaging for energy drinks COBRA grace period Dietary guidelines ICD-10 Antibiotic resistance Pre-diabetes Hypertension Homelessness - impact on health XR-29-2013 related penalty/12 month delay Clinical Laboratory Improvement Amendments (CLIA)/oversight modernization
2015 · fourth_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives HR 3742: Access to Marketplace Insurance Act
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
2015 · third_quarter · Medical/Disease Research/Clinical Labs
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations.
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2015 · third_quarter · Health Issues
Access to Disability Benefits w/Pulmonary Hypertension Pulmonary Hypertension Research activities at NIH Pulmonary Hypertension education & awareness activities at CDC Patient-focused drug development @ FDA Pulmonary Hypertension Research & Diagnosis Act, H.R. 3520 Patients' Access to Treatments Act 21st Century Cures Initiatives
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
| Republican |
| VA |
| Bill Johnson | Republican | OH |
| Bill Pascrell, Jr. | Democratic | NJ |
| Bonnie Watson Coleman | Democratic | NJ |
| Candice S. Miller | Republican | MI |
| Charles B. Rangel | Democratic | NY |
| Charles W. Boustany Jr. | Republican | LA |
| Chris Stewart | Republican | UT |
| Chris Van Hollen | Democratic | MD |
| Christopher H. Smith | Republican | NJ |
| Corrine Brown | Democratic | FL |
| Danny K. Davis | Democratic | IL |
| David E. Price | Democratic | NC |
| David G. Valadao | Republican | CA |
| David P. Joyce | Republican | OH |
| David Young | Republican | IA |
| Devin Nunes | Republican | CA |
| Donald M. Payne, Jr. | Democratic | NJ |
| Donald Norcross | Democratic | NJ |
| E. Scott Rigell | Republican | VA |
| Earl Blumenauer | Democratic | OR |
| Earl L. "Buddy" Carter | Republican | GA |
| Eleanor Holmes Norton | Democratic | DC |
| Eliot L. Engel | Democratic | NY |
| F. James Sensenbrenner, Jr. | Republican | WI |
| Frank C. Guinta | Republican | NH |
| Gene Green | Democratic | TX |
| Gerald E. Connolly | Democratic | VA |
| Grace F. Napolitano | Democratic | CA |
| Jaime Herrera Beutler | Republican | WA |
| James R. Langevin | Democratic | RI |
| Janice D. Schakowsky | Democratic | IL |
| John A. Yarmuth | Democratic | KY |
| John B. Larson | Democratic | CT |
| John K. Delaney | Democratic | MD |
| Joyce Beatty | Democratic | OH |
| Judy Chu | Democratic | CA |
| Keith J. Rothfus | Republican | PA |
| Kurt Schrader | Democratic | OR |
| Leonard Lance | Republican | NJ |
| Lois Capps | Democratic | CA |
| Louise McIntosh Slaughter | Democratic | NY |
| Marcy Kaptur | Democratic | OH |
| Mark Pocan | Democratic | WI |
| Markwayne Mullin | Republican | OK |
| Mike Coffman | Republican | CO |
| Mike Kelly | Republican | PA |
| Niki Tsongas | Democratic | MA |
| Pete Olson | Republican | TX |
| Peter T. King | Republican | NY |
| Richard E. Neal | Democratic | MA |
| Scott Garrett | Republican | NJ |
| Scott H. Peters | Democratic | CA |
| Steve Israel | Democratic | NY |
| Steven M. Palazzo | Republican | MS |
| Tim Ryan | Democratic | OH |
| Timothy J. Walz | Democratic | MN |
| William R. Keating | Democratic | MA |
| Yvette D. Clarke | Democratic | NY |
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Client expense: $4,530,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Client expense: $4,490,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office